Literature DB >> 19121514

Introducing a new entity into discourse: comprehension and production evidence for the status of Dutch er "there" as a higher-level expectancy monitor.

Stefan Grondelaers1, Dirk Speelman, Denis Drieghe, Marc Brysbaert, Dirk Geeraerts.   

Abstract

This paper reports on the ways in which new entities are introduced into discourse. First, we present the evidence in support of a model of indefinite reference processing based on three principles: the listener's ability to make predictive inferences in order to decrease the unexpectedness of upcoming words, the availability to the speaker of grammatical constructions that customize predictive inferences, and the use of "expectancy monitors" to signal and facilitate the introduction of highly unpredictable entities. We provide evidence that one of these expectancy monitors in Dutch is the post-verbal variant of existential er (the equivalent of the unstressed existential "there" in English). In an eye-tracking experiment we demonstrate that the presence of er decreases the processing difficulties caused by low subject expectancy. A corpus-based regression analysis subsequently confirms that the production of er is determined almost exclusively by seven parameters of low subject expectancy. Together, the comprehension and production data suggest that while existential er functions as an expectancy monitor in much the same way as speech disfluencies (hesitations, pauses and filled pauses), er is a higher-level expectancy monitor because it is available in spoken and written discourse and because it is produced more systematically than any disfluency.

Mesh:

Year:  2009        PMID: 19121514     DOI: 10.1016/j.actpsy.2008.11.003

Source DB:  PubMed          Journal:  Acta Psychol (Amst)        ISSN: 0001-6918


  1 in total

1.  Separate streams or probabilistic inference? What the N400 can tell us about the comprehension of events.

Authors:  Gina R Kuperberg
Journal:  Lang Cogn Neurosci       Date:  2016-01-20       Impact factor: 2.331

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.